Guang-Cong Zhang
Overview
Explore the profile of Guang-Cong Zhang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
151
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Yin J, Zhang G, Fang Y, Yu X, Liu T, Dong L, et al.
J Oncol
. 2022 Mar;
2022:5705896.
PMID: 35356253
Introduction: Evidence suggests that the role of senescence in the development of cancer is context-dependent. An orthologue of human pre-mRNA processing factor 19 (Prp19) attenuates the senescence of human endothelial...
12.
Enkhnaran B, Zhang G, Zhang N, Liu H, Wu H, Xuan S, et al.
J Oncol
. 2022 Mar;
2022:1971559.
PMID: 35342408
microRNAs (miRNAs) and miRNA-mediated regulatory networks are promising candidates in the prevention and treatment of cancer, but the role of specific miRNAs involved in hepatocellular carcinoma (HCC) remains to be...
13.
Yu X, Zhang G, Liu H, Zhu J, Liu T, Song G, et al.
Mol Ther Nucleic Acids
. 2022 Jan;
27:390-403.
PMID: 35036052
Pre-mRNA processing factor 19 (PRP19) is elevated in hepatocellular carcinoma (HCC); however, little is known about its function in DNA damage repair in HCC. In this study, analysis of The...
14.
Sun J, Zhang N, Xu R, Zhang G, Liu Z, Abuduwaili W, et al.
J Transl Med
. 2021 Aug;
19(1):347.
PMID: 34389031
Background: Tumor-associated macrophages (TAM) are immunosuppressive cells that contribute to impaired anti-cancer immunity. Iron plays a critical role in regulating macrophage function. However, it is still elusive whether it can...
15.
Zhang G, Liu J, Yu X, Deng Y, Sun Y, Liu T, et al.
Adv Healthc Mater
. 2020 Oct;
9(21):e2000650.
PMID: 33000919
Sorafenib (SOR), a multi-kinase inhibitor for advanced hepatocellular carcinoma (HCC), reveals a limited therapeutic effect due to a lack of selectivity and evident drug resistance. In the present study, bismuth-based...
16.
Shi X, Liu T, Yu X, Balakrishnan A, Zhu H, Guo H, et al.
Oncogene
. 2020 Jul;
39(35):5768-5781.
PMID: 32719439
Cumulative evidence suggests that microRNAs (miRNAs) promote gene expression in cancers. However, the pathophysiologic relevance of miRNA-mediated RNA activation in hepatocellular carcinoma (HCC) remains to be established. Our previous miRNA...
17.
Yu X, Deng Y, Zhang G, Liu J, Liu T, Dong L, et al.
ACS Appl Mater Interfaces
. 2020 Mar;
12(15):17193-17206.
PMID: 32207914
Sorafenib, a multitargeted kinase inhibitor, has been reported to elicit a limited therapeutic effect in hepatocellular carcinoma (HCC). Currently, phototherapy, including photodynamic therapy (PDT) and photothermal therapy (PTT), is emerging...
18.
Yu X, Zhang G, Sun J, Zhu H, Shi X, Song G, et al.
Ann Surg Oncol
. 2020 Mar;
27(5):1546-1557.
PMID: 32157528
Background: The mechanistic target of rapamycin (mTOR) pathway, containing mTOR complex 1 (mTORC1) and mTORC2, is dysregulated in multiple cancers, including hepatocellular carcinoma (HCC). Mammalian lethal with sec-13 protein 8...
19.
Zhang G, Yu X, Sun J, Xiong J, Yang Y, Jiang X, et al.
Aging (Albany NY)
. 2020 Feb;
12(3):2373-2392.
PMID: 32012120
Upregulated ubiquitin-conjugating enzyme E2M (UBE2M) is associated with poor prognosis in malignancies; However, the phenotype and mechanism of action of UBE2M in hepatocellular carcinoma (HCC) remain elusive. Here, we report...
20.
Yu X, Guo H, Liu T, Zhang G, Zhu H, Shi X, et al.
J Cell Biochem
. 2019 Nov;
121(4):2938-2949.
PMID: 31692072
Background: Calcium-binding tyrosine phosphorylation-regulated protein (CABYR) is a group of isoforms produced by alternative splicing and is overexpressed in human malignancies including hepatocellular carcinoma (HCC). However, the prognostic value and...